On October 6—less than two weeks away--hydrocodone combination products (HCPs) will no longer be cla...

Schizophrenia appears to be “heterogenous”—that is, comprising a group of related disorders each of ...

Researchers led by Sophie Molholm, Ph.D., at Albert Einstein College of Medicine tested 43 children ...

The Food and Drug Administration (FDA) has approved Contrave—a combination drug consisting of naltre...

Training a range of mental health clinicians to deliver tobacco treatment services can increase use ...

Early and sustained intervention of children with conduct problems can lower the chances that those ...

People with serious mental illnesses such as schizophrenia or bipolar disorder are at greater risk f...

While previous research has shown a link between benzodiazepines and acute cognitive function, a lin...

Collaborative depression care adapted to obstetrics-gynecology settings appears to have a greater im...